XYLT1 and osteoarthritis: Therefore, pharmacological upregulation of XT-I gene expression along with aggrecan core protein might be expected to increase the amount of functional PG being synthesized and have a therapeutic potential for cartilage repair in OA and also in other degenerative joint diseases.